ReviewHepatology research : the official journal of the Japan Society of Hepatology2025
Low Alanine Aminotransferase Levels in Alcohol Consuming Male Subjects, Carriers of the Common ALDH2 Deficient Variant, ALDH2*2.
Review in Hepatology research : the official journal of the Japan Society of Hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Identification of mitochondria-associated hub genes related to alcohol-associated liver fibrosis progression in aldehyde dehydrogenase 2 deficiency.Frontiers in physiology · 2026Article
- Low Alanine Aminotransferase Levels in Alcohol Consuming Male Subjects, Carriers of the Common ALDH2 Deficient Variant, ALDH2*2.Hepatology research : the official journal of the Japan Society of Hepatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alanine aminotransferase (ALT) is a commonly used indicator of hepatocellular injury in clinical liver disease practice. While a variety of factors influence serum ALT levels, we focus here on the effect of alcohol consumption on ALT levels in the context of the common East Asian aldehyde dehydrogenase 2 (ALDH2) dysfunctional polymorphism, ALDH2*2 (or rs671 E504K missense variant). ALDH2 plays a key role in the detoxification of alcohol-derived metabolite, acetaldehyde. Four of the five studies identified from a literature search showed that individuals with the ALDH2*1/*2 heterozygous genotypes had ALT levels below the normal range if they consume alcoholic beverages despite having only 10%-38% of the normal ALDH2 activity. This effect is consistent and more pronounced in men in studies from different East Asian populations. It is noteworthy that one large study showed that low ALT levels of ALDH2*1/*2 were also observed with excessive alcohol consumption, which is a common risk factor for alcohol-related liver disease (42 g ethanol per day in men). It is unclear if these lower-than-normal ALT levels indicate a hepatoprotective effect or if it is a missed clinical indicator of hepatic injury. As ALT levels in the general practice are used to diagnose potential liver disease, it is therefore necessary to determine whether alcohol-induced decline in ALT may mask the diagnosis of liver disease in an estimated 540 million carriers of the ALDH2*1/*2 genotypes in the East Asian ancestry group in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.